Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction.
Kandzari DE, Tcheng JE, Gersh BJ, Cox DA, Stuckey T, Turco M, Mehran R, Garcia E, Zimetbaum P, McGlaughlin MG, Lansky AJ, Costantini CO, Grines CL, Stone GW; CADILLAC Investigators. Kandzari DE, et al. Among authors: zimetbaum p. Am Heart J. 2006 Jun;151(6):1288-95. doi: 10.1016/j.ahj.2005.08.017. Am Heart J. 2006. PMID: 16781238
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction.
Sorajja P, Gersh BJ, Costantini C, McLaughlin MG, Zimetbaum P, Cox DA, Garcia E, Tcheng JE, Mehran R, Lansky AJ, Kandzari DE, Grines CL, Stone GW. Sorajja P, et al. Among authors: zimetbaum p. Eur Heart J. 2005 Apr;26(7):667-74. doi: 10.1093/eurheartj/ehi167. Epub 2005 Feb 25. Eur Heart J. 2005. PMID: 15734768 Clinical Trial.
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Sorajja P, et al. Among authors: zimetbaum p. Eur Heart J. 2007 Jul;28(14):1709-16. doi: 10.1093/eurheartj/ehm184. Epub 2007 Jun 7. Eur Heart J. 2007. PMID: 17556348 Clinical Trial.
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial. McLaughlin MG, et al. Among authors: zimetbaum p. J Am Coll Cardiol. 2004 Sep 15;44(6):1215-23. doi: 10.1016/j.jacc.2004.06.053. J Am Coll Cardiol. 2004. PMID: 15364322 Free article. Clinical Trial.
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW. Sorajja P, et al. Among authors: zimetbaum p. J Am Coll Cardiol. 2010 Apr 6;55(14):1416-24. doi: 10.1016/j.jacc.2009.11.063. J Am Coll Cardiol. 2010. PMID: 20359590 Free article.
A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial.
Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE; AMEthyst Study Investigators. Kereiakes DJ, et al. Among authors: zimetbaum p. JACC Cardiovasc Interv. 2008 Jun;1(3):248-57. doi: 10.1016/j.jcin.2008.03.009. JACC Cardiovasc Interv. 2008. PMID: 19463308 Free article. Clinical Trial.
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.
Reynolds MR, Lavelle T, Essebag V, Cohen DJ, Zimetbaum P. Reynolds MR, et al. Among authors: zimetbaum p. Am Heart J. 2006 Dec;152(6):1097-103. doi: 10.1016/j.ahj.2006.08.011. Am Heart J. 2006. PMID: 17161061 Free PMC article.
215 results